Displaying 37 (all) recruiting clinical trials.
-
A Phase 1a/1b Study of LY4052031 an Antibody-Drug Conjugate Targeting Nectin-4 in Participants with Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors
This is a Phase 1a/1b study testing a new drug called LY4052031 (an experimental cancer drug) in patients with advanced cancers, including bladder (urothelial ...
Phase
Interventional
-
A PHASE Ib/II OPEN-LABEL MULTICENTER RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE TREATMENT COMBINATIONS IN PATIENTS WITH METASTATIC BREAST CANCER (MORPHEUS-panBC)
This is a Phase 1b/2 clinical study for people with metastatic (which is breast cancer that has spread to other parts of the body ...
Phase
Interventional
-
HYPO2-BOOST GBM trial: Hypoxia-targeted radiotherapy boost for GBM
This is a Phase 1/2 study that will be testing whether a special MRI scan, called dynamic contrast-enhanced MRI (DSC-MRI), can help doctors find ...
Phase
Interventional
-
A Modular Phase I/II Open-label Multicentre Study to Evaluate the Safety Tolerability and Efficacy of AZD3470 a PRMT5 Inhibitor as Monotherapy and in Combination With Anticancer Agent(s) in Participants With Relapsed/Refractory Haematologic Malignancies
This is a Phase I/II, open-label, multicentre clinical study that is testing AZD3470, an investigational oral medicine, in people with blood cancers (haematologic malignancies ...
Phase
Interventional
-
A Phase 1b/2a Double Blind Placebo Controlled Study to Evaluate the Safety Tolerability Pharmacodynamics and Efficacy of CNP-103 in Participants Ages 12-35 with Recent Onset Stage 3 Type 1 Diabetes
The purpose of the CNP-103-CL-201 (CNP-103) Clinical Trial is to evaluate the safety, tolerability, pharmacodynamics, and efficacy of an investigational study therapy, CNP-103, in participants ...Phase
Interventional
-
A Phase 1b/2a Double Blind Placebo Controlled Study to Evaluate the Safety Tolerability Pharmacodynamics and Efficacy of CNP-103 in Participants Ages 12-35 with Recent Onset Stage 3 Type 1 Diabetes
The purpose of this research is to test investigational drug CNP-103 for safety and tolerability in people with type 1 diabetes.Phase
Interventional
-
A phase 1/2 first-in-human study to assess the safety tolerability pharmacokinetics pharmacodynamics and antitumor activity of AVZO-023 as a single agent and in combination with AVZO-021 and/or endocrine therapy in patients
This study is testing the new medicine, AVZO-023-1001 (CDK4 inhibitor), in patients with solid tumors that show changes in CDK/CCND1 genes and in patients ...
Phase
Interventional
